EUVIMEDEUVIMED entdecken
Mixed-Methods-StudieOpen Access · CC BY-NC 4.0

The first AI ‐based Chatbot to promote HIV self‐management: A mixed methods usability study

Yuanchao Ma iD, Sofiane Achiche iD, Gavin Tu, Serge Vicente iD, David Lessard iD, Kim Engler iD, Benoît Lemire iD, MARVIN chatbots Patient Expert Committee, Moustafa Laymouna iD, Alexandra de Pokomandy iD, Joseph Cox iD, Bertrand Lebouché iD

HIV Medicine · 2025

DOI: 10.1111/hiv.13720 ↗

Kurz gefasst

Mixed-Methods-Studie in der Zeitschrift HIV Medicine, 2025. Verfasst von Yuanchao Ma und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Polytechnique Montréal, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: HIV Infections, Self-Management, Artificial Intelligence. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canadian Institutes of Health Research Strategy for Patient-Oriented Research Québec Support Unit-Methodological Developments, PIHVOT program from ViiV Healthcare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We developed MARVIN, an artificial intelligence (AI)‐based chatbot that provides 24/7 expert‐validated information on self‐management‐related topics for people with HIV. This study assessed (1) the feasibility of using MARVIN, (2) its usability and acceptability, and (3) four usability subconstructs (perceived ease of use, perceived usefulness, attitude towards use, and behavioural intention to use).

Methods

In a mixed‐methods study conducted at the McGill University Health Centre, enrolled participants were asked to have 20 conversations within 3 weeks with MARVIN on predetermined topics and to complete a usability questionnaire. Feasibility, usability, acceptability, and usability subconstructs were examined against predetermined success thresholds. Qualitatively, randomly selected participants were invited to semi‐structured focus groups/interviews to discuss their experiences with MARVIN. Barriers and facilitators were identified according to the four usability subconstructs.

Results

From March 2021 to April 2022, 28 participants were surveyed after a 3‐week testing period, and nine were interviewed. Study retention was 70% (28/40). Mean usability exceeded the threshold (69.9/68), whereas mean acceptability was very close to target (23.8/24). Ratings of attitude towards MARVIN's use were positive (+14%), with the remaining subconstructs exceeding the target (5/7). Facilitators included MARVIN's reliable and useful real‐time information support, its easy accessibility, provision of convivial conversations, confidentiality, and perception as being emotionally safe. However, MARVIN's limited comprehension and the use of Facebook as an implementation platform were identified as barriers, along with the need for more conversation topics and new features (e.g., memorization).

Conclusions

The study demonstrated MARVIN's global usability. Our findings show its potential for HIV self‐management and provide direction for further development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsSelf-ManagementArtificial IntelligenceHumansFemaleMaleAdultMiddle AgedSurveys and QuestionnairesFocus GroupsFeasibility StudiesYoung AdultGenerative Artificial Intelligence

Stichwörter der Autor:innen

CanadaHIVantiretroviralartificial intelligencechatbotconversational agentdigital healthfeasibilityimplementation sciencemixed methodsmobile phonepatient and stakeholder engagementself‐managementtelehealthusability

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Polytechnique Montréal, Montreal, Quebec, Canada.
  • Centre for Outcomes Research & Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
  • Infectious Diseases and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, Quebec, Canada.
  • Chronic Viral Illness Service, Division of Infectious Disease, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
  • Faculty of Medicine, Université Laval, Quebec, Quebec, Canada.
  • Department of Family Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.

ORCID-Profile: Yuanchao Ma, Sofiane Achiche, Serge Vicente, David Lessard, Kim Engler, Benoît Lemire, Moustafa Laymouna, Alexandra de Pokomandy, Joseph Cox, Bertrand Lebouché

Förderung

  • Canadian Institutes of Health Research Strategy for Patient-Oriented Research Québec Support Unit-Methodological Developments
  • PIHVOT program from ViiV Healthcare

Zitieren

APA

Ma, Y., Achiche, S., Tu, G., Vicente, S., Lessard, D., Engler, K., Lemire, B., MARVIN chatbots Patient Expert Committee, Laymouna, M., de Pokomandy, A., Cox, J., & Lebouché, B. (2025). The first AI ‐based Chatbot to promote HIV self‐management: A mixed methods usability study. HIV Medicine. https://doi.org/10.1111/hiv.13720

Vancouver

Ma Y, Achiche S, Tu G, Vicente S, Lessard D, Engler K, et al. The first AI ‐based Chatbot to promote HIV self‐management: A mixed methods usability study. HIV Medicine. 2025. doi:10.1111/hiv.13720

BibTeX
@article{Ma2025,
  author = {Ma, Yuanchao and Achiche, Sofiane and Tu, Gavin and Vicente, Serge and Lessard, David and Engler, Kim and Lemire, Benoît and MARVIN chatbots Patient Expert Committee, MARVIN chatbots Patient Expert Committee and Laymouna, Moustafa and de Pokomandy, Alexandra and Cox, Joseph and Lebouché, Bertrand},
  title = {The first AI ‐based Chatbot to promote HIV self‐management: A mixed methods usability study},
  journal = {HIV Medicine},
  year = {2025},
  doi = {10.1111/hiv.13720}
}
Kostenlos starten →